Latest Leadership News

Peet Limited has appointed its long-serving CFO Brett Fullarton as Interim CEO effective immediately, ahead of the planned departure of CEO Brendan Gore on 1 July 2025. This move aims to ensure a smooth leadership transition while a permanent CEO search is underway.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Ioneer Ltd has raised approximately US$16 million through a strongly supported placement to advance its Rhyolite Ridge Lithium-Boron Project, complemented by a Share Purchase Plan targeting an additional US$3.3 million. This funding is pivotal for progressing environmental permitting, project readiness, and strategic partnerships.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Brookfield Infrastructure Partners has sold nearly a quarter of its stake in Dalrymple Bay Infrastructure, reducing its holding but remaining the largest shareholder. This move boosts DBI's free float and could pave the way for its inclusion in the S&P ASX 200 index.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.

Harmoney’s founder Neil Roberts has sold 3.6 million shares, reducing his stake to 15%, as he transitions from Chief Strategy Officer to a non-executive director role.

Ragusa Minerals has terminated its binding agreement with Geopolymer Industries due to unmet conditions, reaffirming its commitment to the Burracoppin rare earths project and exploring fresh opportunities.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

Monash IVF Group has announced the resignation of CEO Michael Knaap, with CFO Malik Jainudeen stepping in as Acting CEO during the leadership transition.

dorsaVi has secured exclusive worldwide rights to cutting-edge RRAM technology from NTU Singapore, promising to revolutionize its wearable sensor products with enhanced performance and energy efficiency. This strategic move positions the company for expansion into healthcare, elite sports, and industrial IoT markets.